» Articles » PMID: 30454029

Visualizing Nationwide Variation in Medicare Part D Prescribing Patterns

Overview
Publisher Biomed Central
Date 2018 Nov 21
PMID 30454029
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To characterize the regional and national variation in prescribing patterns in the Medicare Part D program using dimensional reduction visualization methods.

Methods: Using publicly available Medicare Part D claims data, we identified and visualized regional and national provider prescribing profile variation with unsupervised clustering and t-distributed stochastic neighbor embedding (t-SNE) dimensional reduction techniques. Additionally, we examined differences between regionally representative prescribing patterns for major metropolitan areas.

Results: Distributions of prescribing volume and medication diversity were highly skewed among over 800,000 Medicare Part D providers. Medical specialties had characteristic prescribing patterns. Although the number of Medicare providers in each state was highly correlated with the number of Medicare Part D enrollees, some states were enriched for providers with > 10,000 prescription claims annually. Dimension-reduction, hierarchical clustering and t-SNE visualization of drug- or drug-class prescribing patterns revealed that providers cluster strongly based on specialty and sub-specialty, with large regional variations in prescribing patterns. Major metropolitan areas had distinct prescribing patterns that tended to group by major geographical divisions.

Conclusions: This work demonstrates that unsupervised clustering, dimension-reduction and t-SNE visualization can be used to analyze and visualize variation in provider prescribing patterns on a national level across thousands of medications, revealing substantial prescribing variation both between and within specialties, regionally, and between major metropolitan areas. These methods offer an alternative system-wide and pattern-centric view of such data for hypothesis generation, visualization, and pattern identification.

Citing Articles

Geospatial distribution of the adoption of dipeptidyl-peptidase-4 inhibitors for type 2 diabetes among Medicare beneficiaries.

Cordes J, Glynn R, Walker A, Schneeweiss S Spat Spatiotemporal Epidemiol. 2025; 52:100711.

PMID: 39955125 PMC: 11830116. DOI: 10.1016/j.sste.2025.100711.


A scoping review of medical practice variation research within the informatics literature.

Sohn S, Moon S, Prokop L, Montori V, Fan J Int J Med Inform. 2022; 165:104833.

PMID: 35868231 PMC: 10103076. DOI: 10.1016/j.ijmedinf.2022.104833.


An introduction to machine learning for clinicians: How can machine learning augment knowledge in geriatric oncology?.

Ramsdale E, Snyder E, Culakova E, Xu H, Dziorny A, Yang S J Geriatr Oncol. 2021; 12(8):1159-1163.

PMID: 33795205 PMC: 8478967. DOI: 10.1016/j.jgo.2021.03.012.


The role of county-level socioeconomic status on brand-name prescriptions in Medicare part D: A cross-sectional Study.

Volpi C, Shehadeh F, Mylonakis E Medicine (Baltimore). 2020; 99(9):e19271.

PMID: 32118735 PMC: 7478802. DOI: 10.1097/MD.0000000000019271.

References
1.
Stuart B, Shoemaker J, Dai M, Davidoff A . Regions with higher Medicare Part D spending show better drug adherence, but not lower medicare costs for two diseases. Health Aff (Millwood). 2013; 32(1):120-6. DOI: 10.1377/hlthaff.2011.0727. View

2.
Cordoba G, Siersma V, Lopez-Valcarcel B, Bjerrum L, Llor C, Aabenhus R . Prescribing style and variation in antibiotic prescriptions for sore throat: cross-sectional study across six countries. BMC Fam Pract. 2015; 16:7. PMC: 4316394. DOI: 10.1186/s12875-015-0224-y. View

3.
Kesselheim A, Avorn J, Sarpatwari A . The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform. JAMA. 2016; 316(8):858-71. DOI: 10.1001/jama.2016.11237. View

4.
Porter M, Kerrigan M, Donato B, Ramsey S . Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer. Urol Oncol. 2009; 29(3):252-8. DOI: 10.1016/j.urolonc.2009.03.021. View

5.
Forster D, Frost C . Use of regression analysis to explain the variation in prescribing rates and costs between family practitioner committees. Br J Gen Pract. 1991; 41(343):67-71. PMC: 1371554. View